These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8285926)

  • 41. Syntheses of four peptides from the immunodominant region of hepatitis C viral pathogens using PS-TTEGDA support for the investigation of HCV infection in human blood.
    Kumar KS; Rajasekharan Pillai VN; Das MR
    J Pept Res; 2000 Aug; 56(2):88-96. PubMed ID: 10961543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of synthetic peptides as additional antigens for detecting antibodies to hepatitis C virus].
    Semiletov IuA; Firsova TV; Kruglov IV; Alekseenkova TI; Petrakova NV; Kalinina TI; Shibnev VA
    Vopr Virusol; 1998; 43(3):107-9. PubMed ID: 9702806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epitope mapping of the NS4 and NS5 gene products of hepatitis C virus and the use of a chimeric NS4-NS5 synthetic peptide for serodiagnosis.
    Rosa C; Osborne S; Garetto F; Griva S; Rivella A; Calabresi G; Guaschino R; Bonelli F
    J Virol Methods; 1995 Oct; 55(2):219-32. PubMed ID: 8537460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of monoclonal antibodies and epitope mapping of the NS4 protein of hepatitis C virus.
    Masalova OV; Lakina EI; Abdulmedzhidova AG; Atanadze SN; Semiletov YA; Shkurko TV; Burkov AN; Ulanova TI; Pimenov VK; Novikov VV; Khudyakov YE; Fields H; Kushch AA
    Immunol Lett; 2002 Oct; 83(3):187-96. PubMed ID: 12095709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antigenic specificity of recombinant polypeptides, containing fragments of hepatitis E virus proteins].
    Alatortseva GI; Amiantova II; Grinev AA; Nesterenko LN; Sukhanova LL; Titaev AV; Dement'eva EV; Semiletov IuA; Kuzin SN; Gol'tsov VA
    Vopr Virusol; 1999; 44(2):60-4. PubMed ID: 10358898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Type-specific antibodies to hepatitis C virus in sera from patients with various hematologic diseases].
    Garanzha TA; Tupoleva TA; Guliaeva AA; Firsova TV; Semiletov IuA; Alekseenkova TI; Ianina MV; Golosova TV; Shibnev VA; Filatov FP
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (2):72-6. PubMed ID: 11548266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solid phase synthesis of peptide aldehyde protease inhibitors. Probing the proteolytic sites of hepatitis C virus polyprotein.
    Ede NJ; Eagle SN; Wickham G; Bray AM; Warne B; Shoemaker K; Rosenberg S
    J Pept Sci; 2000 Jan; 6(1):11-8. PubMed ID: 10674715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Serological study of hepatitis C virus NS5 protein epitopes and their clinical and diagnostic significance].
    Kruglov IV; Znoĭko OO; Finogenova MP; Ogienko OL; Ianina MV; Sergeeva NA; Braginskiĭ DM; Doroshenko NV; Shibnev VA; Semiletov IuA
    Vopr Virusol; 2000; 45(1):14-7. PubMed ID: 10695037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Symmetrical Boc-amino acid anhydrides for economical peptide syntheses on a solid phase.
    Wieland T; Birr C; Flor F
    Angew Chem Int Ed Engl; 1971 May; 10(5):336. PubMed ID: 5005189
    [No Abstract]   [Full Text] [Related]  

  • 50. Minimal Reconstitution of Membranous Web Induced by a Vesicle-Peptide Sol-Gel Transition.
    Ho JCS; Steininger C; Hiew SH; Kim MC; Reimhult E; Miserez A; Cho N; Parikh AN; Liedberg B
    Biomacromolecules; 2019 Apr; 20(4):1709-1718. PubMed ID: 30856330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of the C-terminal undeca- and protected docosapeptide of bovine insulin B-chain.
    Hemmasi B; Stüber W; Bayer E
    Hoppe Seylers Z Physiol Chem; 1984 Apr; 365(4):485-92. PubMed ID: 6376320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel and comprehensive synthetic approach for the elucidation of protein antigenic structures. Determination of the full antigenic profile of the alpha-chain of human haemoglobin.
    Kazim AL; Atassi MZ
    Biochem J; 1980 Oct; 191(1):261-4. PubMed ID: 6162459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides.
    Chang JC; Seidel C; Ofenloch B; Jue DL; Fields HA; Khudyakov YE
    Virology; 1999 Apr; 257(1):177-90. PubMed ID: 10208931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of a linear epitope in the nonstructural region 4 of hepatitis C virus with reactivity to seroconversion antibodies.
    Wienhues U; Ihlenfeldt HG; Seidel C; Schmitt U; Kraas W; Jung G
    Virology; 1998 Jun; 245(2):281-8. PubMed ID: 9636367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Synthesis and antigenic activity of peptides from the C-terminal part of the NS4-protein of the hepatitis A virus].
    Semiletov IuA; Firsova TV; Kuzin SN; Khudiakov IuE; Shibnev VA
    Bioorg Khim; 1993 Nov; 19(11):1128-31. PubMed ID: 8285926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Synthesis and antigenic activity of peptides from core- and NS3-proteins of hepatitis C virus].
    Semiletov IuA; Firsova TV; Shibnev VA; Viazov SO
    Bioorg Khim; 1993 Jan; 19(1):126-9. PubMed ID: 8387305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigenic epitopes of the hepatitis A virus polyprotein.
    Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA
    Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.